Get started
RocketTickers

Krystal Biotech’s KB105 Granted Orphan Drug Designation by the F

Long
Krystal Biotech, Inc. (NASDAQ:KRYS)  
RocketTickers  
NASDAQ:KRYS   Krystal Biotech, Inc.
Beyond Technical Analysis
1
0
beyondta
KRYS: Krystal Biotech
2018-08-09 08:00:00
Krystal Biotech’s KB105 Granted Orphan Drug Designation by the FDA to Treat Patients With TGM-1 Deficient Autosomal Recessive Congenital Ichthyosis
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.